Qualigen Therapeutics, Inc. · CIK 1460702
Qualigen Therapeutics, Inc.
These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.
Filings
1
Original notices
1
Amendments
0
Activity
Aug 13, 2025
through Aug 13, 2025
through Aug 13, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot: how to read these fields
- Reported offering amount
- $4,500,000
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $4,500,000
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Same reported sales compensation recipient
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- FARADAY FUTURE INTELLIGENT ELECTRIC INC. · CIK 1805521
- Ocient Holdings LLC · CIK 1766325
- Ocient Inc. · CIK 1766293
Form D filings (1)
-
0001641172-25-023575D · Aug 13, 2025 · BiotechnologyOffering: $4,500,000Sold: $4,500,000